A comprehensive global analysis in Nature Medicine 2026 reveals striking disparities in cancer burden attributable to modifiable risk factors across income levels. High-income regions show 78% of cancer cases linked to preventable exposures, while upper-middle income regions account for 65%, lower-middle income regions 52%, and low-income regions 38%. These region-specific findings challenge assumptions about uniform cancer aetiology and highlight distinct prevention opportunities tailored to each population’s exposure patterns.
The data demonstrate that prevention strategies cannot be uniformly applied across all settings. High-income nations may benefit from targeted interventions addressing obesity and alcohol-related cancers, while other regions face different dominant risk factor profiles requiring customised public health responses. This evidence base empowers health systems to prioritise cancer control investments according to local epidemiological realities, maximising the impact of limited prevention resources.
Read the full article on GMJ Newsroom.
Was this article helpful?
